Therapeutic Area
Therapeutic Excellence
Redefining Value in Obesity Drug Development: A Focus on the Full Cardiometabolic Continuum
Aug 07, 2026
Explore how GLP-1s are transforming cardiometabolic drug development, moving beyond weight loss to target the underlying pathophysiology of obesity and its associated metabolic...